Next Article in Journal
Endoscopic and Histopathological Findings of the Esophagus, Stomach, and Duodenum in Patients with Crohn’s Disease from a Reference Center in Bahia, Brazil
Previous Article in Journal
A Rare Cause of Drug-Induced Pancytopenia: Trimethoprim–Sulfamethoxazole-Induced Pancytopenia
Article

Case Series of Multisystem Inflammatory Syndrome (MIS-C) in Children during the SARS-CoV-2 Pandemic in Latvia

1
Department of Continuing Education, Children’s Clinical University Hospital, LV-1004 Riga, Latvia
2
Department of Paediatrics, Riga Stradins University, LV-1007 Riga, Latvia
*
Author to whom correspondence should be addressed.
Clin. Pract. 2021, 11(2), 363-373; https://doi.org/10.3390/clinpract11020051
Received: 17 April 2021 / Revised: 6 June 2021 / Accepted: 7 June 2021 / Published: 11 June 2021
The total number of COVID-19 positive cases in Latvia has escalated rapidly since October 2020, peaking in late December 2020 and early January 2021. Children generally develop COVID-19 more mildly than adults; however, it can be complicated by multisystem inflammatory syndrome in children (MIS-C). This case study aims were to assess demographic characteristics and the underlying medical conditions, and clinical, investigative and treatment data among 13 MIS-C patients using electronic medical records. All 13 had acute illness or contact with someone who was COVID-19 positive two to six weeks before MIS-C onset. Only five of the 13 were symptomatic during the acute COVID-19 phase. The median age was 8.8 years; 11/13 patients were male, 10/13 had been previously healthy, and all 13 patients tested positive for SARS-CoV-2 by RT-PCR or antibody testing. The most commonly involved organ systems were the gastrointestinal (13/13), hematologic (13/13), cardiovascular (13/13), skin and mucosa (13/13), and respiratory (12/13) ones. The median hospital stay was 13 (interquartile range, 11 to 18) days; 7/13 patients received intensive care, 6/13 oxygen support, and 5/13 received inotropic support. No deaths occurred. During the current pandemic, every child with a fever should have a clearly defined epidemiological history of COVID-19, a careful clinical assessment of possible multiple organ-system involvement, with a special focus on children with severe abdominal pain and/or skin and mucocutaneous lesions. View Full-Text
Keywords: COVID-19; SARS-CoV-2; multisystem inflammatory syndrome in children (MIS-C) COVID-19; SARS-CoV-2; multisystem inflammatory syndrome in children (MIS-C)
Show Figures

Figure 1

MDPI and ACS Style

Racko, I.; Smane, L.; Klavina, L.; Pucuka, Z.; Roge, I.; Pavare, J. Case Series of Multisystem Inflammatory Syndrome (MIS-C) in Children during the SARS-CoV-2 Pandemic in Latvia. Clin. Pract. 2021, 11, 363-373. https://doi.org/10.3390/clinpract11020051

AMA Style

Racko I, Smane L, Klavina L, Pucuka Z, Roge I, Pavare J. Case Series of Multisystem Inflammatory Syndrome (MIS-C) in Children during the SARS-CoV-2 Pandemic in Latvia. Clinics and Practice. 2021; 11(2):363-373. https://doi.org/10.3390/clinpract11020051

Chicago/Turabian Style

Racko, Iveta, Liene Smane, Lizete Klavina, Zanda Pucuka, Ieva Roge, and Jana Pavare. 2021. "Case Series of Multisystem Inflammatory Syndrome (MIS-C) in Children during the SARS-CoV-2 Pandemic in Latvia" Clinics and Practice 11, no. 2: 363-373. https://doi.org/10.3390/clinpract11020051

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop